Related Experiment Video

Updated: Jun 23, 2026

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
07:49

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis

D J Grainger1, P R Kemp, J C Metcalfe

  • 1Department of Biochemistry, University of Cambridge, UK.

Nature Medicine
|January 1, 1995
PubMed

Insights

Transforming growth factor-beta (TGF-beta) is a key inhibitor of atherosclerosis. Lower active TGF-beta levels in patients with advanced atherosclerosis suggest its diagnostic and prognostic potential.

Area of Science:

  • Cardiovascular Research
  • Molecular Biology
  • Immunology

Background:

  • Atherosclerosis is a major cardiovascular disease.
  • Transforming growth factor-beta (TGF-beta) is implicated in cardiovascular health.
  • The role of TGF-beta in atherosclerosis requires further elucidation.

Purpose of the Study:

  • To investigate the association between active TGF-beta levels and atherosclerosis.
  • To determine the diagnostic and prognostic significance of TGF-beta in atherosclerosis.
  • To explore potential therapeutic interventions targeting TGF-beta.

Main Methods:

  • Sera from patients with advanced atherosclerosis and normal coronary arteries were analyzed.
  • Active TGF-beta concentrations were measured.
  • Correlation with known atherosclerosis risk factors was assessed.
  • The effect of aspirin medication on TGF-beta levels was examined.

Main Results:

  • Patients with advanced atherosclerosis exhibited significantly lower active TGF-beta serum concentrations (fivefold difference) compared to controls.
  • The correlation between active TGF-beta and atherosclerosis was stronger than for established risk factors.
  • Aspirin medication was associated with increased active TGF-beta levels.

Conclusions:

  • Reduced active TGF-beta is strongly associated with advanced atherosclerosis.
  • Active TGF-beta holds potential as a diagnostic and prognostic biomarker for atherosclerosis.
  • TGF-beta levels can be influenced by therapeutic interventions like aspirin, suggesting treatment possibilities.

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay11:38

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay

Published on: September 14, 2021

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...